EUDAW Market Analysis

Fundamentals

Updated daily after market close
P/E ratio
EPS (TTM)0.0% YoY
Profit margin-40.7%
Market cap

Valuation

Forward P/E
PEG ratio
P/B
P/S (TTM)
EV/EBITDA

Profitability & growth

ROE (TTM)
0.0%
Operating margin
-34.8%
Revenue growth YoY
78.9%
Dividend yield
Beta
0.59

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

About EUDA Health Holdings Limited

Company profile

EUDA Health Holdings Limited is an innovative biotechnology company focused on creating advanced therapies for dermatological and chronic health conditions. Leveraging scientific innovation and technology, EUDA is dedicated to addressing significant unmet medical needs with its robust pipeline of transformative products. Guided by a highly experienced leadership team, the company is strategically poised to seize growth opportunities in the dynamic healthcare sector, ultimately striving to enhance patient outcomes and quality of life.

Classification

Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
60 KAKI BUKIT PLACE, SINGAPORE, SINGAPORE
Fiscal year end
December
Latest quarter
Mar 31, 2026
Shares outstanding$0
52W high$0.14
52W low$0.02

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer